1. Home
  2. JFB vs PULM Comparison

JFB vs PULM Comparison

Compare JFB & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JFB
  • PULM
  • Stock Information
  • Founded
  • JFB 2014
  • PULM 2003
  • Country
  • JFB United States
  • PULM United States
  • Employees
  • JFB N/A
  • PULM N/A
  • Industry
  • JFB
  • PULM Biotechnology: Pharmaceutical Preparations
  • Sector
  • JFB
  • PULM Health Care
  • Exchange
  • JFB NYSE
  • PULM Nasdaq
  • Market Cap
  • JFB 35.3M
  • PULM 30.9M
  • IPO Year
  • JFB 2025
  • PULM N/A
  • Fundamental
  • Price
  • JFB $4.06
  • PULM $6.14
  • Analyst Decision
  • JFB
  • PULM
  • Analyst Count
  • JFB 0
  • PULM 0
  • Target Price
  • JFB N/A
  • PULM N/A
  • AVG Volume (30 Days)
  • JFB 73.3K
  • PULM 21.3K
  • Earning Date
  • JFB 01-01-0001
  • PULM 05-09-2025
  • Dividend Yield
  • JFB N/A
  • PULM N/A
  • EPS Growth
  • JFB N/A
  • PULM N/A
  • EPS
  • JFB 0.19
  • PULM N/A
  • Revenue
  • JFB $27,273,091.00
  • PULM $7,806,000.00
  • Revenue This Year
  • JFB N/A
  • PULM N/A
  • Revenue Next Year
  • JFB N/A
  • PULM $134.88
  • P/E Ratio
  • JFB $22.64
  • PULM N/A
  • Revenue Growth
  • JFB 12.72
  • PULM 6.96
  • 52 Week Low
  • JFB $3.39
  • PULM $1.68
  • 52 Week High
  • JFB $4.87
  • PULM $10.40
  • Technical
  • Relative Strength Index (RSI)
  • JFB N/A
  • PULM 37.17
  • Support Level
  • JFB N/A
  • PULM $7.16
  • Resistance Level
  • JFB N/A
  • PULM $7.33
  • Average True Range (ATR)
  • JFB 0.00
  • PULM 0.53
  • MACD
  • JFB 0.00
  • PULM -0.15
  • Stochastic Oscillator
  • JFB 0.00
  • PULM 5.00

About JFB JFB CONSTRUCTION HOLDINGS

JFB Construction Holdings is a commercial and residential real estate construction and development company. It is engaged in retail corporate buildouts, multifamily community developments and luxury residential homes, with a focus on fostering long-term relationships with clients, partners, and communities. The company operates in three distinct business segments: Commercial Construction, Residential Construction, and Real Estate Development. Key revenue is generated from Commercial Construction: This segment includes all activities related to the construction of commercial properties such as office buildings, retail spaces, and industrial facilities.

About PULM Pulmatrix Inc.

Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.

Share on Social Networks: